Fas ligand (FasL)-dependent apoptosis has been implicated in the control of
tissue-damaging inflammatory responses in several immune privileged sites.
Here, we present data demonstrating that FasL is expressed on human tropho
blast cells throughout pregnancy and transduces growth inhibitory/death sig
nals in cells bearing its receptor, Fas (CD95). Immunohistochemical analysi
s detected FasL-positive staining in the trophoblast layer of villi of firs
t- and second-trimester and term (no labor) placental tissues, as well as i
n freshly isolated cytotrophoblasts representing these gestational ages. In
contrast, term placental tissues and cytotrophoblasts from labor-associate
d deliveries exhibited significantly reduced FasL expression, suggesting th
at parturition altered the characteristics of trophoblast cells. FasL-speci
fic immunoblotting of cytotrophoblast cell lysates further confirmed these
results. To assess the functionality of FasL expressed on cytotrophoblasts,
we co-cultured these cells with Fas-bearing Jurkat T cells. Cytotrophoblas
ts from early pregnancy, or term with no labor, significantly inhibited gro
wth in Jurkat cells, evident even at a 1:1 effector:target cell ratio, as d
etermined by the incorporation of [H-3]thymidine. Similar results were obta
ined when a FasL-positive colon carcinoma cell line, SW620, was used in pla
ce of cytotrophoblasts. Tn contrast, term cytotrophoblasts from labor deliv
eries exhibited poor FasL expression and were quantitatively much less prof
icient in inhibiting [H-3]thymidine incorporation in Jurkat cells. These da
ta indicate that FasL could participate in modulating the inflammatory resp
onses associated with labor and suggest intrinsic molecular differences in
the placental microenvironment before and after labor.